Related by context. Frequent words. (Click for all words.) 68 MGCD# [002] 61 TELCYTA 61 limiting toxicity 60 pegloticase 60 PXD# 59 talactoferrin 59 FavId 59 relapsed multiple myeloma 59 HGS ETR1 59 ALN RSV# 58 refractory multiple myeloma 58 valopicitabine 57 DAVANAT R 57 CoFactor 56 PS# [001] 56 PEG Interferon lambda 56 tolerated dose MTD 56 MGCD# [001] 56 cutaneous T cell 56 CA4P 56 Perifosine 55 pralatrexate 55 Restanza 55 nitric oxide donating 55 CYC# 55 IMGN# 55 INCB# [002] 55 vandetanib 55 decitabine 55 Atiprimod 55 TORISEL 55 ALN VSP 55 vernakalant oral 55 phase IIb 54 Topical Interferon Alpha 2b 54 tamibarotene 54 Zerenex 54 sapacitabine 54 Phase 2a trial 54 orBec R 54 Locteron 54 antisense drug 54 FOLOTYN 54 Taxotere ® 54 Taxotere R 54 ATryn R 54 Azixa 54 MDV# 53 voreloxin 53 Phase Ib 53 VEGF Trap 53 HspE7 53 AP# [003] 53 tgAAC# 53 ISIS # 53 CYT# 53 OXi# 52 NGX# 52 tivozanib 52 ZADAXIN 52 tesetaxel 52 Marqibo 52 AZD# 52 DAVANAT ® 52 APD# 52 perifosine 52 PF # [001] 52 Amigal 52 Phase 1b clinical 52 bafetinib 52 oncology indications 52 PROVENGE 51 ZYBRESTAT 51 palifosfamide 51 PRX # 51 MBP# [001] 51 TREANDA 51 TNFerade 51 belinostat 51 radiolabeled 51 ADVEXIN 50 cytarabine 50 TG# [001] 50 safety tolerability pharmacokinetics 50 APF# 50 RG# [001] 50 AACR NCI EORTC 50 GVAX 50 resistant ovarian cancer 50 preclinical studies 50 antitumor activity 50 oncolytic viruses 50 CUDC 50 Phase IIa clinical 50 Phase IIb clinical 50 GRN#L 50 dose cohorts 50 Phase 2a 50 eculizumab 50 Genasense 50 hematological malignancies